Evolocumab Data Show No Adverse Cognitive Effects Over 2 Years
Physician's Weekly,
Cognitive decline rates same as placebo in FOURIER…
Cognitive decline rates same as placebo in FOURIER…
The dominant approach to slowing atherosclerosis remains a mix of pharmaceuticals that can, separately, reduce blood pressure…
News reports suggest new drugs may replace statins. PSCK9 inhibitors are useful, but only along with statins in high risk…
Richard Lehman reviews the latest research in the top medical…